Journal
Blood Advances
Publication Date
3-24-2026
Volume
10
Issue
6
First Page
1947
Last Page
1951
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2025018546
Rights and Permissions
Iacoboni G, Kyvsgaard ER, Navarro Garcés V, Russler-Germain DA, Lewis K, Martín García-Sancho A, Carro I, Thompson PA, Therwhanger D, Quintela D, Ku M, Gómez P, Valencia E, Vega G, Jiménez-Ubieto A, Bastos-Oreiro M, Serna A, Husby S, De La Cruz B, Luan J, Camarillas S, Medina L, Cabero A, Córdoba R, Canales M, Sancho JM, Bosch F, Sureda A, Schuster S, Cheah CY, Hutchings M, Barba P, Abrisqueta P. Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma. Blood Adv. 2026 Mar 24;10(6):1947-1951. doi: 10.1182/bloodadvances.2025018546. © 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Iacoboni, Gloria; Russler-Germain, David A; Luan, Jing; and et al., "Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma." Blood Advances. 10, 6. 1947 - 1951. (2026).
https://digitalcommons.wustl.edu/oa_4/6513
Additional Links
Supplemental material is available for this article at publisher site.
